AL

Ordinary Fully Paid Deferred Settlement

ALCDA · AU · Healthcare / Health Information Services

1.27AUD

Price History

Full chart

Market Stats

Open1.22
Day Range1.22 – 1.29
52-Week Range1.15 – 1.30
Volume78.05K
Market Cap171.43M
P/E (TTM)63.50
Forward P/E1.33
EPS0.02
Dividend Yield0.00%
Beta0.99
50-Day Avg1.25
200-Day Avg1.25

About

Alcidion Group Limited, together with its subsidiaries, develops and sells digital health software solutions for healthcare organisations in Australia, New Zealand, and the United Kingdom. It offers Miya Precision, a fast healthcare interoperability resource (FHIR) events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). The company's platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions. In addition, the company offers Smartpage, a smartphone and web-based system for hospital communication and task management; and product implementation, product support and maintenance, systems integration, and data analysis services. The company was formerly known as Alcidion Corporation Pty Ltd and changed its name to Alcidion Group Limited in December 2015. Alcidion Group Limited was founded in 2000 and is headquartered in South Yarra, Australia.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMs. Kate Quirke
  • Employees141
  • Headquarters9 Yarra Street, South Yarra, VIC, Australia, 3141, Australia
  • Websitehttps://www.alcidion.com

Leadership

  • Ms. Kate QuirkeGroup MD, CEO & Executive Director
  • Mr. Matthew GeppChief Financial Officer
  • Ms. Julia StevensChief Operating Officer
  • Mr. Sean WalkerChief Technology Officer
  • Mr. Nick WhiteChief Marketing Officer
  • Ms. Amanda JamesChief People Officer
  • Ms. Kaye HockingChief Product Officer
  • Dr. Paul DeffleyChief Medical Officer & MD of UK
  • Ms. Tracy McClellandChief Clinical Information Officer
  • Mr. Michael Sapountzis AGIA, B.Com., L.L.B., M.A.I.C.D.Company Secretary

Financials

Income Statement

Currency: AUD2023-06-302024-06-302026-06-30
Total Revenue40.40M37.06M41.81M
Growth (%)--8.27%+12.82%
Cost of Revenue5.63M5.14M10.18M
Gross Profit34.77M31.92M31.62M
Gross Margin86.07%86.14%75.64%
Operating Expense39.50M40.60M39.14M
Operating Income-4.73M-8.68M-7.52M
Operating Margin-11.70%-23.42%-17.99%
EBITDA-1.43M-4.50M6.38M
EBITDA Margin-3.53%-12.13%15.25%
Net Income-3.62M-8.42M2.29M
Net Income Margin-8.95%-22.71%5.47%
Interest Expense125.00K103.00K57.00K
Interest Expense % of Total Revenue0.31%0.28%0.14%

Balance Sheet

Currency: AUD2022-06-302023-06-302024-06-302026-06-30
Total Assets128.35M120.68M114.46M121.88M
Total Liabilities34.40M30.52M27.52M31.01M
Total Equity93.95M90.17M86.94M90.87M
Cash17.34M14.64M11.80M20.64M

Cash Flow

Currency: AUD2022-06-302023-06-302024-06-302025-06-302026-06-30
Financing Cash Flow51.33M-616.00K4.34M--800.00K
Capital Expenditure311.00K454.00K53.00K0226.00K
Free Cash Flow685.00K-285.00K-7.18M-6.62M

Key Statistics & Ratios

Market Cap171.43M
Enterprise Value151.60M
Trailing P/E63.50
Forward P/E1.33
Price / Sales3.32
Price / Book1.80
EPS0.02
Book Value0.676
Revenue (TTM)51.64M
Gross Profit (TTM)41.46M
EBITDA5.34M
Profit Margin4.43%
Operating Margin4.94%
Return on Equity2.56%
Return on Assets1.34%
Shares Outstanding134.98M
Shares Float98.42M
Beta0.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%